Clinical Trial Update: A Non-inferiority Phase 2 Study to Evaluate the Safety and Efficacy of PEG-rhGH in the Treatment of AGHD [Phase 2]

View source ↗

Summary

A non-inferiority Phase 2 trial is evaluating the safety and efficacy of PEG-rhGH for adult growth hormone deficiency. The study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• PEG-rhGH (pegylated recombinant human growth hormone)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Adult Growth Hormone Deficiency | Phase 2 | Status: UNKNOWN